Should You Buy Palantir Stock Before August 3? | PLTR Stock Analysis
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA19 Jul 2026, 12:45 UTC
AI-generated source summary
Palantir (PLTR) is showing strong fundamental performance, with Q1 2026 revenue growing 85% year-over-year and U.S. commercial revenue up 133% year-over-year. The company raised its full-year revenue guidance to $7.65-$7.662 billion and increased its U.S. commercial revenue guidance to over $3.224 billion, representing at least 120% growth. Furthermore, Palantir's cash from operations is strong at $899 million (55% margin), with $8 billion in cash and equivalents and short-term U.S. Treasury securities, and no debt. The stock's forward P/E ratio, currently around 63.79, is trading near its lower range of the past year, which was approximately 40-50. The intrinsic value per share is calculated at $151.64, suggesting the stock is currently undervalued at its market price of $133.76.
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
